Creative Planning Sells 54,250 Shares of Abbott Laboratories

Creative Planning trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 751,772 shares of the healthcare product maker’s stock after selling 54,250 shares during the quarter. Creative Planning’s holdings in Abbott Laboratories […]

Related Keywords

Canada , Boston , Massachusetts , United States , Roberte Funck , Lisad Earnhardt , , Capital International Investors , Royal Bank , Barclays , Capital Research Global Investors , Goldman Sachs Group , Citigroup , Manufacturers Life Insurance Company , Norges Bank , Abbott Laboratories , Exchange Commission , Securities Exchange Commission , Creative Planning , Free Report , Research Global Investors , International Investors , Laboratories Stock Down , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,